How much does Everlab cost?

Premium tier relative to the other clinics variis tracks. AU$799–$2,999/yr; flagship "Protocol" AU$2,999

Regulator on record: TGA / AHPRA. No registration reference is on file.

Clinic

Everlab

Melbourne · Australia

AU$65M Series A led by Airtree (16 Jun 2026), with Plural, Left Lane, b2venture and Pat Cummins; ~AU$80M total raised; UK named as next market. Transparent pricing.

At a glance

Location: Melbourne
Price: PremiumAU$799–$2,999/yr; flagship "Protocol" AU$2,999
Status: Open
Verification: Verified by variis

Practical

Visiting this clinic

City: Melbourne
Market: Australia
Address: Melbourne (national)
Founded: 2023
Price tier: PremiumAU$799–$2,999/yr; flagship "Protocol" AU$2,999
Services listed: None recorded

Trust

Regulation and verification

Regulator: TGA / AHPRA
Registration: No reference on file
Licensed: Date not published
variis check: Verified
Sources: 1 on file

Get in touch

Contact

Address: Melbourne (national)
Website: www.businesswire.com
Phone: No public number published
Email: No public address published

Offering

What you can book

Services: None recorded
Protocols: None linked
Practitioners: 1 listed
Price tier: Premium

People

Who practises here (1)

variis does not publish portraits of named practitioners without a licence to do so. Each profile states which register the person is on and whether variis has checked it.

Dr Steven LuCMO, EverlabDescribed by the RACGP as "a Victorian GP" (general practice). No specialty confirmed against the AHPRA register.No registration on file

Common questions

Where is Everlab?: Melbourne (national)
How much does Everlab cost?: Premium tier relative to the other clinics variis tracks. AU$799–$2,999/yr; flagship "Protocol" AU$2,999
Is Everlab licensed?: Regulator on record: TGA / AHPRA. No registration reference is on file.

Latest moves

Dated developments variis is tracking.

Capital · AustraliaEverlab closes an AU$65M Series A16 Jun

Keep reading

Related coverage from the newsroom.

Singapore · Clinical

Singapore launches SPICE program to screen and prevent decline in older adults

Global · Protocol

GLP-1s and healthspan: a 2026 reader’s primer

The NUS Academy for Healthy Longevity team celebrates the launch of its Clinical Trial Centre, the facility behind PROMETHEUS, a precision geromedicine study testing tailored lifestyle, supplement and drug approaches to ageing and age-related disease.